한글목차

인공지능(AI) 진단 시장은 2025년에는 22억 780만 달러로 추정되고, 2032년에는 84억 8,160만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 CAGR은 21.2%를 나타낼 전망입니다.

인공지능(AI)은 헬스케어에서 강력한 가능성을 지니고 있어 방대한 양의 데이터를 신속하고 상세하게 분석할 수 있는 능력이 기대되고 있습니다.

시장 역학 :

의료진단의 실천은 인공지능(AI)의 개발과 채용에 따라 급속히 변화하고 있습니다. 루고리즘, 클라우드 스토리지 및 전자 의료 기록의 데이터 세트 이용 가능성과 같은 진보로 진단 및 건강 관리에서 중요한 역할을 수행할 수 있습니다.

2017년 12월의 방사선 의학에 있어서의 AI의 응용에 관한 PubMed의 논문에서는 다음의 브레이크스루는 혁신적인 방사선 장치가 아니고, AI의 통합에 의해 초래된다고 연구되었습니다. 이 통합은 단계적으로 행해질 가능성이 높습니다. 이미지 데이터와 구조의 자동 세분화를 실시하고, 중요한 분석 가치를 가져와 방사선과 의사의 시간 단축에 공헌하고 있습니다.향후 10년간, AI 기반의 방사선과 솔루션은 방사선과의에 의한 분석에 앞서, 정량화, 세분화, 패턴 인식등의 루틴 태스크를 실행하기 위해서 사용됩니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 인공지능(AI) 진단 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 CAGR을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
• 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 아래의 파라미터를 바탕으로 세계의 인공지능(AI) 진단 시장 주요 기업을 프로파일하고 있습니다.
• 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 세계의 인공지능(AI) 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자는 세계의 인공지능(AI) 진단 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 감염증의 발생률의 상승
  • 체온계 사용에 대한 우려
  • 인공지능(AI) 진단장치에 대한 높은 수요
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER's 분석
• 합병과 인수 시나리오

제4장 세계의 인공지능(AI) 진단 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 인공지능(AI) 진단 시장, 구성 요소별(2020-2032년)

• 소프트웨어
• 하드웨어
• 서비스

제6장 세계의 인공지능(AI) 진단 시장, 진단 유형별(2020-2032년)

• 심장학
• 종양학
• 병리학
• 방사선학
• 신경학
• 기타

제7장 세계의 인공지능(AI) 진단 시장, 지역별(2020-2032년)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• Vuno Inc.
• CHC Healthcare Group
• Aidoc
• Imbio
• Alivecor Inc.
• Digital Diagnostics
• Retina AI
• Canon Medical Systems USA
• Healthy IO
• Milliman Inc.
• GE Healthcare
• Arterys
• Alivecor Inc.
• Riverain
• Lucid Health
• Qure.AI
• Cardiologs

제9장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Artificial Intelligence Diagnostics Market is estimated to be valued at USD 2,207.8 Mn in 2025 and is expected to reach USD 8,481.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 21.2% from 2025 to 2032.

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study:

• This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

• Global Artificial Intelligence Diagnostics Market, By Component:
  • Software
  • Hardware
  • Services
• Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Neurology
  • Others
• Global Artificial Intelligence Diagnostics Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Vuno Inc.
  • CHC Healthcare Group
  • Aidoc
  • Imbio
  • Alivecor Inc.
  • Digital Diagnostics
  • Retina AI
  • Canon Medical Systems USA
  • Healthy IO
  • Milliman Inc.
  • GE Healthcare
  • Arterys
  • Alivecor Inc.
  • Riverain
  • Lucid Health
  • Qure.AI
  • Cardiologs

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Component
  • Market Snapshot, By Service Type
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising incidence of infectious diseases
  • Concerns about the use of thermometers
  • High demand for Artificial Intelligence (AI) diagnostics devices
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Artificial Intelligence (AI) Diagnostics Market, By Component, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Hardware
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnostics Market, By Diagnostics Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Pathology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Radiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Artificial Intelligence (AI) Diagnostics Market, By Geography, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)

8. Competitive Landscape

• Vuno Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CHC Healthcare Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aidoc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Imbio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alivecor Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Digital Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Retina AI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Canon Medical Systems USA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Healthy IO
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Milliman Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Arterys
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alivecor Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Riverain
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lucid Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qure.AI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardiologs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us